Alumis Inc. (ALMS) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ALMS SEC filings page.
Alumis Inc. (ALMS) reported $7.4M in revenue over the twelve months to Jun 30, 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Alumis is funding a development-stage business through heavy R&D spending, with operating cash needs still closely matching accounting losses.
In FY2025, an operating loss of$454M coincided with operating cash flow of-$370M and free cash flow of-$370M . That close alignment indicates the reported loss is translating largely into cash consumption, rather than being driven mainly by non-cash accounting charges.
FY2025 R&D was 16.1x reported revenue, while SG&A reached
A
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Alumis Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Alumis Inc. held $308.5M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $369.5M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Alumis Inc. scores 30/100 among other emerging companies.
Not available for Alumis Inc., and counted as zero in the overall score.
Alumis Inc. spent $386.0M on research and development in fiscal year 2025, which was 80.8% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Alumis Inc. scores 98/100 among other emerging companies.
Not available for Alumis Inc., and counted as zero in the overall score.
Alumis Inc.'s operations used $369.5M of cash in fiscal year 2025, against $255.1M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Alumis Inc. scores 12/100 among other emerging companies.
Alumis Inc.'s cash, cash equivalents and investments came to $308.5M at the end of fiscal year 2025, against $110.6M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Alumis Inc. scores 81/100 among other emerging companies.
Alumis Inc. scores -1.12, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($886.6M) relative to total liabilities ($110.6M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Alumis Inc. passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
Alumis Inc. reported a net loss of $243.3M while operations used $369.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Alumis Inc. generated $1.7M in revenue in Q2 2026. This represents a decrease of 37.7% from the same quarter a year earlier. Against the prior quarter it is down 4.5%.
Alumis Inc.'s EBITDA was -$148.1M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 6.0% from the same quarter a year earlier. Against the prior quarter it is down 51.8%.
Alumis Inc. reported -$142.2M in net income in Q2 2026. This represents a decrease of 339.7% from the same quarter a year earlier. Against the prior quarter it is down 52.8%.
Alumis Inc. earned -$1.11 per diluted share (EPS) in Q2 2026. Against the prior quarter it is down 50.0%.
Cash & Balance Sheet
Alumis Inc. recorded an outflow of $81.7M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 23.6% from the same quarter a year earlier. Against the prior quarter it is up 6.3%.
Alumis Inc. held $63.7M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
Alumis Inc.'s ROE was -31.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 43.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 15.0 percentage points.
Not reported for Q2 2026.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Alumis Inc. invested $85.3M in research and development in Q2 2026. This represents a decrease of 21.5% from the same quarter a year earlier. Against the prior quarter it is up 4.7%.
Alumis Inc. invested $237K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 61.5% from the same quarter a year earlier. Against the prior quarter it is up 44.5%.
Not reported for Q2 2026.
ALMS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.7M-37.7% | $1.7M-90.0% | $1.9M | $2.1M | $2.7M | $17.4M | N/A | N/A |
| R&D Expenses | $85.3M-21.5% | $81.5M-15.6% | $82.8M | $97.8M+11.4% | $108.8M+123.9% | $96.6M+130.3% | N/A | $87.8M+132.4% |
| SG&A Expenses | $23.4M-32.2% | $18.6M-16.5% | $15.6M | $19.5M+84.6% | $34.5M+354.8% | $22.3M+295.9% | N/A | $10.6M+77.1% |
| Operating Income | -$148.9M-5.9% | -$98.4M+3.1% | -$96.4M | -$115.3M-17.2% | -$140.5M-150.3% | -$101.5M-113.3% | N/A | -$98.4M-124.9% |
| EBITDA | -$148.1M-6.0% | -$97.5M+3.1% | -$95.6M | -$114.4M-17.2% | -$139.6M-152.3% | -$100.7M-115.0% | N/A | -$97.6M-124.6% |
| Income Tax | -$1.8M+79.5% | N/A | N/A | $0 | -$8.6M | N/A | N/A | $0 |
| Net Income | -$142.2M-339.7% | -$93.1M+6.0% | -$92.9M | -$110.8M-18.9% | $59.3M+205.0% | -$99.0M-98.5% | N/A | -$93.1M-114.7% |
| EPS (Basic) | -$1.11-242.3% | -$0.74+59.3% | -$0.94-308.7% | -$1.06+38.7% | $0.78+103.4% | -$1.82+91.3% | -$0.23+98.7% | -$1.73+91.2% |
| EPS (Diluted) | -$1.11 | -$0.74 | -$0.94-308.7% | -$1.06 | $0.77 | -$1.82 | -$0.23+98.7% | -$1.73 |
| Diluted Shares (Avg) | 128M | 125M | N/A | 104M | 77M | 65M | N/A | 54M |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Interest Expense.
ALMS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $560.6M-8.2% | $671.6M+157.0% | $411.9M+20.8% | $488.0M+18.3% | $610.9M+130.4% | $261.3M | $341.0M+280.5% | $412.6M |
| Current Assets | $514.1M-0.7% | $532.4M+136.1% | $318.2M+3.9% | $393.3M+4.2% | $517.6M+130.2% | $225.5M | $306.2M+473.8% | $377.3M |
| Cash & Equivalents | $63.7M-58.0% | $63.9M-50.3% | $89.7M-47.1% | $65.3M-69.4% | $151.8M-2.2% | $128.5M+14.7% | $169.5M+268.6% | $213.4M+295.7% |
| Short-Term Investments | $438.6M+31.1% | $459.1M+472.3% | $218.8M+84.3% | $312.5M+110.5% | $334.6M+514.8% | $80.2M | $118.7M+3916.8% | $148.5M |
| Long-Term Investments | $0 | $46.6M | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $108.5M-13.6% | $104.6M+12.5% | $110.6M+36.8% | $103.2M+60.9% | $125.6M-82.2% | $93.0M | $80.9M-81.1% | $64.2M |
| Current Liabilities | $76.2M-10.9% | $70.9M+17.3% | $73.3M+44.0% | $65.4M+95.2% | $85.6M+156.1% | $60.5M | $50.9M+143.9% | $33.5M |
| Non-Current Liabilities | $32.2M-19.5% | $33.7M+3.5% | $37.3M+24.5% | $37.8M+23.4% | $40.0M-94.0% | $32.5M | $30.0M-92.7% | $30.7M |
| Total Equity | $452.2M-6.8% | $567.0M+236.9% | $301.3M+15.8% | $384.8M+10.4% | $485.3M+210.6% | $168.3M+143.6% | $260.1M+176.7% | $348.4M+215.0% |
| Retained Earnings | -$1.1B-62.9% | -$994.9M-31.3% | -$901.9M-36.9% | -$808.9M-43.5% | -$698.2M-48.3% | -$757.5M | -$658.6M-80.8% | -$563.8M |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
ALMS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$81.5M+23.4% | -$87.1M-8.4% | -$71.9M+3.8% | -$110.9M-32.4% | -$106.4M-103.4% | -$80.4M-81.5% | -$74.8M-121.7% | -$83.8M-152.0% |
| Depreciation & Amortization | $800K-11.1% | $871K+3.3% | $867K+5.7% | $900K+12.5% | $900K+12.5% | $843K+11.2% | $820K+12.9% | $800K+166.7% |
| Stock-Based Compensation | $14.3M-23.4% | $12.3M+76.4% | N/A | $9.8M+33.9% | $18.6M+494.8% | $7.0M+163.3% | N/A | $7.3M+222.0% |
| Capital Expenditures | $237K-61.5% | $164K+343.2% | $0-100.0% | $0-100.0% | $616K+42.6% | $37K-76.1% | $366K-69.8% | $779K-64.1% |
| Free Cash Flow | -$81.7M+23.6% | -$87.2M-8.5% | -$71.9M+4.3% | -$110.9M-31.2% | -$107.0M-102.9% | -$80.4M-81.0% | -$75.1M-115.0% | -$84.5M-138.7% |
| Investing Cash Flow | $68.7M-46.9% | -$285.7M-824.6% | $95.0M+207.0% | $24.0M+125.8% | $129.4M+495.2% | $39.4M+309.6% | $30.9M+846.9% | -$93.2M-1330.1% |
| Financing Cash Flow | $12.6M | $347.0M | $1.3M+26260.0% | $0-100.0% | N/A | N/A | $5K-100.0% | $235.2M+500221.3% |
| Share Buybacks | N/A | N/A | $0 | $0 | N/A | N/A | $0 | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
ALMS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -8956.4% | -5652.4% | -4999.7% | -5580.4% | -5271.5% | -583.9% | N/A | N/A |
| Net Margin | -8557.2% | -5344.8% | -4817.6% | -5360.7% | 2225.1% | -569.1% | N/A | N/A |
| Return on Equity | -31.4%-43.7pp | -16.4%+42.4pp | -30.8% | -28.8%-2.1pp | 12.2% | -58.8% | N/A | -26.7% |
| Return on Assets | -25.4%-35.1pp | -13.9%+24.0pp | -22.6% | -22.7%-0.1pp | 9.7%+31.0pp | -37.9% | N/A | -22.6% |
| Current Ratio | 6.74+0.7x | 7.51+3.8x | 4.34-1.7x | 6.01-5.2x | 6.05-0.7x | 3.73 | 6.01+3.5x | 11.26 |
| Debt-to-Equity | 0.240.0x | 0.18-0.4x | 0.37+0.1x | 0.27+0.1x | 0.26 | 0.55 | 0.31 | 0.18 |
| Asset Turnover | 0.000.0x | 0.00-0.1x | 0.00 | 0.00 | 0.00 | 0.07 | N/A | N/A |
| FCF Margin | -4918.0% | -5011.3% | -3727.7% | -5368.3% | -4012.3% | -462.3% | N/A | N/A |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Alumis Inc. ALMS | FY2025 | $24.1M | -$243.3M | N/A | $886.6M | 37/100 |
| Erasca, Inc. ERAS | FY2025 | N/A | -$124.5M | N/A | $5.2B | — |
| Prothena Corporation plc PRTA | FY2025 | $9.7M | -$244.1M | N/A | $429.2M | 55/100 |
| Corvus Pharmaceuticals, Inc. CRVS | FY2025 | N/A | -$15.3M | N/A | $916.9M | — |
| iTeos Therapeutics, Inc. ITOS | FY2024 | $35.0M | -$134.4M | N/A | $448.7M | 33/100 |
| Astria Therapeutics, Inc. ATXS | FY2024 | N/A | -$94.3M | N/A | $718.1M | — |
Where Alumis Inc. Ranks
Frequently Asked Questions
What is Alumis Inc.'s annual revenue?
Alumis Inc. (ALMS) reported $24.1M in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is Alumis Inc. profitable?
No, Alumis Inc. (ALMS) reported a net income of -$243.3M in fiscal year 2025.
What is Alumis Inc.'s EBITDA?
Alumis Inc. (ALMS) had EBITDA of -$450.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Alumis Inc.'s return on equity (ROE)?
Alumis Inc. (ALMS) has a return on equity of -80.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Alumis Inc.'s free cash flow?
Alumis Inc. (ALMS) recorded an outflow of $370.2M in free cash flow during fiscal year 2025. This represents a -44.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Alumis Inc.'s operating cash flow?
Alumis Inc. (ALMS) recorded an outflow of $369.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Alumis Inc.'s total assets?
Alumis Inc. (ALMS) had $411.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Alumis Inc.'s capital expenditures?
Alumis Inc. (ALMS) invested $653K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Alumis Inc. spend on research and development?
Alumis Inc. (ALMS) invested $386.0M in research and development during fiscal year 2025.
What is Alumis Inc.'s current ratio?
Alumis Inc. (ALMS) had a current ratio of 4.34 as of fiscal year 2025, which is generally considered healthy.
What is Alumis Inc.'s debt-to-equity ratio?
Alumis Inc. (ALMS) had a debt-to-equity ratio of 0.37 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Alumis Inc.'s return on assets (ROA)?
Alumis Inc. (ALMS) had a return on assets of -59.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Alumis Inc.'s P/E ratio?
Alumis Inc. (ALMS) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $886.6M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Alumis Inc.'s price-to-sales ratio?
Alumis Inc. (ALMS) trades at 120x sales, its market capitalization divided by revenue of $7.4M revenue, trailing 12 months to June 30, 2026. The market capitalization is $886.6M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Alumis Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Alumis Inc. (ALMS) held $308.5M in cash, cash equivalents and investments, and reported an operating cash outflow of $369.5M over that year. Dividing the one by the other, the reported balance equals about 10 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Alumis Inc.'s Altman Z-Score?
Alumis Inc. (ALMS) has an Altman Z-Score of -1.12, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Alumis Inc.'s Piotroski F-Score?
Alumis Inc. (ALMS) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Alumis Inc.'s earnings high quality?
Alumis Inc. (ALMS) reported a net loss of $243.3M while operations used $369.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Alumis Inc.?
Alumis Inc. (ALMS) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.